Pharmacogenomics in Clinical Practice
Intro -- Contents -- Principles of Pharmacogenetics -- 1 Introduction -- 2 The Significance of Pharmacogenetics in the Context of Personalized (Precision) Medicine -- 3 Influence of Genetic Inter-individual Variations on Therapeutic Outcomes -- 4 Gene/Drug Interaction-Level of Evidence for the Development of Pharmacotherapeutic Guidelines -- 5 Conclusion -- References -- Principles of Xenobiotic Metabolism (Biotransformation) -- 1 Introduction -- 2 Oxidations -- 2.1 Cytochrome P450 -- 2.2 Alcohol and Aldehyde Dehydrogenases -- 2.3 Peroxidases -- 2.4 Xanthine Oxidoreductase and Aldehyde Oxidase -- 2.5 Flavin-Containing Monooxygenase -- 2.6 Monoamine Oxidase -- 3 Reductions -- 4 Hydrolysis and Conjugations -- 4.1 Hydrolysis -- 4.2 Glucuronidation -- 4.3 Sulfoconjugation -- 4.4 Methylation -- 4.5 Acetylation -- 4.6 Conjugation with Amino Acids -- 4.7 Conjugation with Glutathione -- 5 Metabolic Reactions in Therapeutic Drug Monitoring -- References -- Pharmacogenomics of Drug-Metabolizing Enzymes -- 1 Introduction -- 2 Enzymes Involved in Phase I Drug Metabolism -- 2.1 CYP2D6 -- 2.2 CYP2C19 -- 2.3 CYP2C9 -- 2.4 CYP3A4/A5 -- 2.5 Other Isoforms of Cytochrome CYP P450 Enzyme System (CYP1A2, 2A6, 2B6, 4F2) -- 3 Enzymes Involved in Phase II Drug Metabolism -- 3.1 Thiopurine Methyltransferase-TPMT -- 3.2 N-acetyltransferase 2-NAT2 -- 3.3 Glutathione S-transferase-GSTM1, GSTT1, GSTP1 -- 3.4 UDP Glucuronyl Transferase-UGT1A1 -- 3.5 Sulfotransferase-SULT -- 4 Vitamin K Epoxy Reductase-VKORC1 -- 5 Pharmacogenetic profile of CYP2C9 and VKORC1 in anticoagulant therapy -- 6 Conclusion -- References -- Role of Membrane Transporters in Pharmacogenomics -- 1 Introduction -- 2 ABC Superfamily -- 2.1 ABCB1 (P-gp, from P-Glycoprotein -- MDR1, from Multidrug Resistance Protein) -- 2.2 ABCG2 (BCRP, from the Breast Cancer Resistance Protein, also Known as MXR or MCF-7)..
Medienart: |
E-Book |
---|
Erscheinungsjahr: |
2024 ©2023 |
---|---|
Erschienen: |
Cham: Springer International Publishing AG ; 2024 ©2023 |
Ausgabe: |
1st edition |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Primorac, Dragan [HerausgeberIn] |
---|
Links: |
ebookcentral.proquest.com [lizenzpflichtig] |
---|
ISBN: |
---|
Anmerkungen: |
Description based on publisher supplied metadata and other sources |
---|
Umfang: |
1 Online-Ressource (484 Seiten) |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
1879493454 |
---|
LEADER | 01000cam a2200265 4500 | ||
---|---|---|---|
001 | 1879493454 | ||
003 | DE-627 | ||
005 | 20240201135801.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240130s2024 xx |||||o 00| ||eng c | ||
020 | |a 9783031459030 |9 978-3-031-45903-0 | ||
035 | |a (DE-627)1879493454 | ||
035 | |a (DE-599)KEP100258417 | ||
035 | |a (EBC)EBC31054872 | ||
035 | |a (EBL)EBL31054872 | ||
035 | |a (EBP)100258417 | ||
040 | |a DE-627 |b ger |c DE-627 |e rda | ||
041 | |a eng | ||
245 | 1 | 0 | |a Pharmacogenomics in Clinical Practice |
250 | |a 1st edition | ||
264 | 1 | |a Cham |b Springer International Publishing AG |c 2024 | |
264 | 4 | |c ©2023 | |
300 | |a 1 Online-Ressource (484 Seiten) | ||
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Description based on publisher supplied metadata and other sources | ||
520 | |a Intro -- Contents -- Principles of Pharmacogenetics -- 1 Introduction -- 2 The Significance of Pharmacogenetics in the Context of Personalized (Precision) Medicine -- 3 Influence of Genetic Inter-individual Variations on Therapeutic Outcomes -- 4 Gene/Drug Interaction-Level of Evidence for the Development of Pharmacotherapeutic Guidelines -- 5 Conclusion -- References -- Principles of Xenobiotic Metabolism (Biotransformation) -- 1 Introduction -- 2 Oxidations -- 2.1 Cytochrome P450 -- 2.2 Alcohol and Aldehyde Dehydrogenases -- 2.3 Peroxidases -- 2.4 Xanthine Oxidoreductase and Aldehyde Oxidase -- 2.5 Flavin-Containing Monooxygenase -- 2.6 Monoamine Oxidase -- 3 Reductions -- 4 Hydrolysis and Conjugations -- 4.1 Hydrolysis -- 4.2 Glucuronidation -- 4.3 Sulfoconjugation -- 4.4 Methylation -- 4.5 Acetylation -- 4.6 Conjugation with Amino Acids -- 4.7 Conjugation with Glutathione -- 5 Metabolic Reactions in Therapeutic Drug Monitoring -- References -- Pharmacogenomics of Drug-Metabolizing Enzymes -- 1 Introduction -- 2 Enzymes Involved in Phase I Drug Metabolism -- 2.1 CYP2D6 -- 2.2 CYP2C19 -- 2.3 CYP2C9 -- 2.4 CYP3A4/A5 -- 2.5 Other Isoforms of Cytochrome CYP P450 Enzyme System (CYP1A2, 2A6, 2B6, 4F2) -- 3 Enzymes Involved in Phase II Drug Metabolism -- 3.1 Thiopurine Methyltransferase-TPMT -- 3.2 N-acetyltransferase 2-NAT2 -- 3.3 Glutathione S-transferase-GSTM1, GSTT1, GSTP1 -- 3.4 UDP Glucuronyl Transferase-UGT1A1 -- 3.5 Sulfotransferase-SULT -- 4 Vitamin K Epoxy Reductase-VKORC1 -- 5 Pharmacogenetic profile of CYP2C9 and VKORC1 in anticoagulant therapy -- 6 Conclusion -- References -- Role of Membrane Transporters in Pharmacogenomics -- 1 Introduction -- 2 ABC Superfamily -- 2.1 ABCB1 (P-gp, from P-Glycoprotein -- MDR1, from Multidrug Resistance Protein) -- 2.2 ABCG2 (BCRP, from the Breast Cancer Resistance Protein, also Known as MXR or MCF-7). | ||
700 | 1 | |a Primorac, Dragan |e herausgeberin |4 edt | |
700 | 1 | |a Höppner, Wolfgang |e herausgeberin |4 edt | |
700 | 1 | |a Bach-Rojecky, Lidija |e herausgeberin |4 edt | |
776 | 1 | |z 9783031459023 | |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9783031459023 |
856 | 4 | 0 | |u https://ebookcentral.proquest.com/lib/kxp/detail.action?docID=31054872 |m X:EBC |x Aggregator |z lizenzpflichtig |
912 | |a ZDB-30-PQE | ||
912 | |a GBV_ILN_20 | ||
912 | |a ISIL_DE-84 | ||
912 | |a SYSFLAG_1 | ||
912 | |a GBV_KXP | ||
912 | |a SSG-OPC-PHA | ||
912 | |a SSG-OPC-DE-84 | ||
951 | |a BO | ||
980 | |2 20 |1 01 |x 0084 |b 4472258110 |h CATDESC_EBC-EB |u CATDESC_EBC-EB |y z |z 01-02-24 | ||
981 | |2 20 |1 01 |x 0084 |r https://ebookcentral.proquest.com/lib/tubraunschweig-ebooks/detail.action?docID=31054872 | ||
995 | |2 20 |1 01 |x 0084 |a CATDESC_EBC-EB | ||
995 | |2 20 |1 01 |x 0084 |a ACQ |